Clinical trial
Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced…
NCT00161278 · University of Michigan Rogel Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00161278 |
|---|---|
| Title | Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling |
| Official title | Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced Non-Small Cell Lung Cancer Through Gene Expression Profiling. |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Advanced Non-Small Cell Lung Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Carboplatin, Paclitaxel, Gene expression profiling (analysis) of tumor samples |
| Enrollment | 1 |
| Start date | Dec 1, 2004 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Jul 30, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: